National Health Investors annual debt-to-ebitda ratio
2014
2015
2022
2023
2024
2025
National Health Investors Debt-to-EBITDA Ratio Growth & History (NHI)
National Health Investors's debt-to-ebitda ratio was 4.23 for fiscal 2025.
View full National Health Investors company overviewNational Health Investors annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.23 | −0.12 | −2.68% |
| 2024 | 2024-12-31 | 4.34 | −0.03 | −0.69% |
| 2023 | 2023-12-31 | 4.37 | −2.06 | −31.97% |
| 2022 | 2022-12-31 | 6.43 | — | — |
| 2015 | 2015-12-31 | 4.49 | −1.62 | −26.47% |
| 2014 | 2014-12-31 | 6.11 | — | — |
National Health Investors quarterly debt-to-ebitda ratio
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.09 | — | — |
| Q1 2026 | 2026-03-31 | 4.42 | — | — |
| Q4 2025 | 2025-12-31 | 4.23 | — | — |
National Health Investors debt-to-ebitda ratio trends
Between the periods ended 2014-12-31 and 2025-12-31, National Health Investors's debt-to-ebitda ratio decreased from 6.11 to 4.23, a change of −1.89. The latest reported quarter, Q2 2026, shows 4.09.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review National Health Investors source filings ↗